Skip to main content
Caplight Logo









HaplScience

HaplScience

Private
SeoulHealthcare & Life Scienceshttps://haplnscience.com

Last Round

Series B

Jan 19, 2021

Total Funding Raised

$29.19M

Company Overview

HaplScience is a biotechnology company developing first-in-class therapies for chronic diseases and aging-related conditions based on the HAPLN1 protein.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

regenerative medicinedrug discoveryage-related diseaseslongevity biotechtherapeutic developmenttissue repairorganoid technologybiotechnologyanti-aging researchpharmaceutical R&Dlicensing agreementbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HaplScience Comparables

Compare HaplScience with similar companies based on industry and business-model similarity.

HaplScience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MediSpan Co., Ltd.
82%
Juvena Therapeutics
81%
Oisín Biotechnologies
80%

HaplScience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJan 19, 2021
Series AJul 12, 2019

Key People

Founding team and executive leadership

Hubert Hakbae Choi

CEO

Executive Team

HaplScience Investors

Notable investors and investment history

HaplScience investors
InvestorRounds
DSC InvestmentSeries B, Series A
Ministry of Science and ICT of South KoreaGrant
Company K PartnersSeries B, Series A
JB InvestmentSeries B
Lifecore PartnersSeries B
STIC VenturesSeries B
National Research Foundation of KoreaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 15, 2026

    Monthly visitors increased 1160% MoM, reaching 1.7K.

  • Nov 9, 2025

    Monthly visitors grew 336% MoM, from 434 to 1.9K.

HaplScience Filings

Explore SEC and related filing metadata, where available.

HaplScience filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about HaplScience's valuation, stock price, and market status.

Is HaplScience a public or private company?

HaplScience is a private company.

What is the current stock price of HaplScience?

HaplScience is a private company with no public stock price. Caplight tracks HaplScience's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is HaplScience worth (valuation)?

Valuation information for HaplScience is not publicly available.

Can I buy HaplScience stock?

HaplScience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was HaplScience's last funding round?

HaplScience's most recent funding round was Series B on January 19, 2021.

Who are the main investors in HaplScience?

Key investors in HaplScience include DSC Investment, Ministry of Science and ICT of South Korea, Company K Partners, JB Investment, Lifecore Partners.

Will HaplScience IPO soon?

No public IPO plans have been announced for HaplScience.

How can I track HaplScience secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor HaplScience's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeoul
Employee Range8
Year FoundedN/A
Last FundingJan 19, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?